Acumen Pharmaceuticals ABOS
NASDAQ ABOS
$2.03 +0.01 (+0.74%)
As of: Oct 21, 2026 · 9:58 AM EDT

Acumen Pharmaceuticals (ABOS) Asset Utilization Ratio (2021 - 2024)

Updated

Analysis

Acumen Pharmaceuticals (ABOS) Asset Utilization Ratio (2021 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,136.25 Bn 1,104.84 Bn 19.71 Bn 0.62
2 Johnson & Johnson 615.56 Bn 534.09 Bn 17.26 Bn 0.49
3 AbbVie 506.32 Bn 479.44 Bn 12.70 Bn 0.47
4 Merck 367.72 Bn 322.10 Bn 12.21 Bn 0.52
5 Novartis Ag 298.15 Bn 262.14 Bn 11.24 Bn 0.46
6 Astrazeneca 262.32 Bn 236.01 Bn 12.86 Bn 0.51
7 Amgen 236.40 Bn 191.80 Bn 7.24 Bn 0.40
8 Gilead Sciences 191.30 Bn 165.50 Bn 6.22 Bn 0.58
9 Pfizer 170.97 Bn 117.62 Bn 10.94 Bn 0.31
10 Acumen Pharmaceuticals 146.31 Mn -335.76 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 0.03
Sep 30, 2023 0.04
Jun 30, 2023 0.03
Mar 31, 2023 0.02
Dec 31, 2022 0.01
Sep 30, 2022 0.01
Jun 30, 2022 0.00
Mar 31, 2022 0.00
Dec 31, 2021 0.00
API Access

Acumen Pharmaceuticals Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=ABOS&period=max&api_key=YOUR_API_KEY